Loading...
Symbols:
Loading...
Symbols:
Pfizer Inc. (PFE)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Pfizer Inc. (PFE)
527 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on PFE
- SA Editor Miriam Metzinger(48)
- Mike Huckman(43)
- Bespoke Investment Group(30)
- Derek Lowe(29)
- SA Editor Eli Hoffmann(28)
Most popular authors
(tracked in watchlists)
- David Fry(1017)
- Philip Davis(587)
- Bespoke Investment Group(571)
- Trader Mark(488)
- Bill Cara(428)
Most commented on authors
- Bespoke Investment Group(135)
- SA Editor Eli Hoffmann(104)
- Mike Stathis (101)
- Devin Hobbes(100)
- Mike Huckman(96)
- Dividend Aristocrats Outperform in November
- Thanksgiving Economic Data: Mostly Turkeys
- Johnson & Johnson Is the Latest FDA Casualty
- Stocks Offering 'Healthy' Returns
- Sell Risk, Buy Pharma
- NYSE Listings with Market Caps Greater Than $100B
- Stocks Will Continue to Erode In This Busted Economy
- Navigating the Micro-Cap Biotech Minefield
- My Dividend Portfolio: I Like Beer
- Options Trader: Friday Outlook
- S&P 100 P/E Ratios: How Low Can They Go?
- Pharmas and Biotech: Vying for Outsize Insulin Profits
- Dow Member Changes Since the 10/02 Low
- Markets Strike Fresh Lows
- Berkowitz, Rodriguez and Pabrai: Examining Q3 Filings
- Regenerative Medicine: Big Pharma's Next Frontier
- Defensive Dividend Stocks Offering Value Now, And Comparative ETFs
- Ultra Brite Outlook for Colgate - Barron's
- Top Global Dividend Stocks
- General Electric Moves On Down the Largest Company List
- S&P 500 Dividend Aristocrats and Your Portfolio
- Obama and Big Pharma: The Case for Pfizer
- Market Update: Roche/Genentech Deal, AstraZeneca's New Statin, Yahoo, Microsoft Deal?
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- ETFI Global Healthcare Sector PerfomIdex
- China Bio in Review: More Fallout from Economic Crisis
- Wuxi, Pfizer Strengthen Relationship in New Deal
- Winners and Losers in a Democratic Administration
- Dow Price Targets
- Not Running Out to Buy Shares in Pfizer
- A Buy & Hold Forever Dividend Stock Portfolio
- Reality Check on the Big Pharma Rumor Mill
- 3 Lower Risk Stocks: Pfizer, Analog Devices, Chevron
- Pfizer Needs Isis More Than Isis Needs Pfizer
- Buying Aggressively, As Per Ben Graham
- S&P 500 Dividend Aristocrats: Withstanding the Test of Time
- Don't Buy Into Share Buybacks
- Six Healthcare Stocks at Sale Prices
- Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
- Big Pharma Feels Free Market Pain
- Pfizer Phasing Out Cholesterol
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
4 new today)